Medscape News, Perspective & Articles

• 1 in 10 Children With Cancer Injured by Medication Error In a multisite study, researchers found that most medication errors in children with cancer could be prevented.
  Medscape Medical News, February 09, 2023
• Real-World Trends in the Evaluation of Medical Products This commentary summarizes recent trends within pharmacoepidemiologic research, highlighting the need to evaluate the real-world effects of medical products outside of preapproval RCTs.
  American Journal of Epidemiology, February 09, 2023
• Hospital-at-home Implementation Under the CMS Waiver This study explored the barriers and facilitators of Hospital-at-Home care under the Centers for Medicare & Medicaid Services waiver.
  Journal of the American Geriatrics Society, February 08, 2023
• More Data Back Guillain-Barré Risk With Janssen COVID Shot Observed cases of Guillain-Barré syndrome after receipt of the Janssen shot were two to three times greater than background rates within 3-6 weeks of vaccination, new US surveillance data show.
  Medscape Medical News, February 03, 2023
• SGLT2 Inhibitors and the Risk of Pneumonia and Septic Shock SGLT2 inhibitors are commonly used in the treatment of type 2 diabetes. Could these agents also help lower the risk of pneumonia and septic shock in these patients?
  Journal of Clinical Endocrinology & Metabolism, February 01, 2023
• Opioids and Changes in Cognitive Function in Older Adults This study aimed to characterize the relationship between prescription opioids use and long-term cognitive function.
  Journal of the American Geriatrics Society, January 26, 2023
• Angioedema Risk Jumps When Switching HF Meds The risk for angioedema increases when switching from an ARB or ACE inhibitor to ARNI, observational data suggest. Better to start RAS inhibition using the ARNI in the first place, researchers say.
  Medscape Medical News, January 25, 2023
• Galcanezumab in Refractory Episodic and Chronic Cluster Headache This narrative review examines the safety and efficacy of the CGRP galcanezumab in patients with episodic or chronic refractory cluster headache.
  Headache, January 25, 2023
• No Spike in Overdose Deaths From Relaxed Buprenorphine Regs The easing of buprenorphine prescribing and dispensing regulations during the COVID pandemic did not increase buprenorphine-involved overdose deaths, new research shows.
  Medscape Medical News, January 24, 2023
• Alert FDA OKs Zanubrutinib (Brukinsa) for CLL or SLL The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
  Medscape Medical News, January 20, 2023
• Nursing Year in Review: Short Staffing, Strikes, and Suicides On the frontlines of a continuing pandemic with new variants and emerging viruses, nurses faced trauma, legal battles, and strains on safety and well-being. An experienced nurse looks forward and back.
  Medscape Business of Medicine, January 12, 2023
• Two Drug Classes Appear Effective for Gastroparesis Treatment Even still, there remains an unmet need for efficacious therapies for gastroparesis.
  Medscape Medical News, January 12, 2023
• Health Risks Low for Children Exposed in Utero to Cancer, Chemo Children exposed in utero to cancer and its treatment do not appear to have any long-term health consequences as a result of this exposure, a Danish study suggests.
  Medscape Medical News, January 11, 2023
• A PICU Checklist for Interprofessional Rounds This newly developed checklist for interprofessional rounds in the pediatric intensive care unit could help improve patient care and safety.
  American Journal of Critical Care, January 05, 2023
• The Use of Erenumab for Migraine Prophylaxis During Pregnancy Is the calcitonin gene-related peptide erenumab safe to use for migraine prophylaxis throughout pregnancy?
  Headache, January 04, 2023
• Exacerbation History Found Flawed as COPD Risk Predictor Exacerbation history alone wasn't as effective as risk-prediction models for predicting exacerbation in chronic obstructive pulmonary disease.
  Medscape Medical News, December 30, 2022
• Top Studies in HER2+ Breast Cancer From SABCS 2022   Top studies in HER2+ breast cancer from SABCS 2022 include initial findings of the DESTINY-Breast03 and -Breast02 trials, and de-escalation strategies for patients with stage I HER2+ disease.
  Medscape, December 30, 2022
• FDA Serotonin Syndrome Warning Unnecessary? Although the antibiotic linezolid carries a warning against its use by patients taking antidepressants, owing to risk for serotonin syndrome, new research suggests that that concern may be unnecessary.
  Medscape Medical News, December 29, 2022
• IV Ketamine Effective for Resistant Depression in Older Adults? Almost half of older adults who received ketamine infusions for treatment-resistant depression achieved a response, and 25% achieved remission, in a new pilot study.
  Medscape Medical News, December 28, 2022
• LAMA/LABA Combos Tied to Varying Adverse Events in COPD A national cohort study showed significant differences in AE and cardiovascular event risk among three treatments.
  Medscape Medical News, December 23, 2022